by Agilent Technologies
Polaris HPLC Columns
Performs Well Under Aqueous Conditions
In areas like drug discovery where target compounds are increasingly polar, it is critical to have a reversed-phase column that performs well under aqueous conditions. Retention is critical, but cannot come with troublesome secondary interactions. Likewise, phase collapse and shifting retention times need to be avoided. The answer is our Polaris line of polar modified columns.
| Vendor | Agilent Technologies | Pore size | 180 |
| Brand | Agilent Polaris | Surface Area | 200 |
| Modifification | Silica/C18 | Carbon Load, % | 12.1 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability to | 10.0 | |
| Internal Diameter |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| MACHEREY-NAGEL | NUCLEOSIL C18 | Reversed-Phase | Silica/C18 | 3.0 mm | 125 mm | 5.0 μm | 100 Å | 213.00 |
| Thermo Fisher Scientific | BioBasic | Reversed-Phase | Silica/C18 | 2.1 mm | 100 mm | 5.0 μm | 300 Å | On request |
| Dikma Technologies Inc. | Bio-Bond C18 | Reversed-Phase | Silica/C18 | 4.6 mm | 250 mm | 3.0 μm | 300 Å | 621.00 |
| GRACE | Prevail C18 | Reversed-Phase | Silica/C18 | 2.1 mm | 150 mm | 3.0 μm | 110 Å | On request |
| Merck | LiChrospher® | Reversed-Phase | Silica/C18 | 4.0 mm | 250 mm | 10.0 μm | 100 Å | On request |
| Bonna-Agela Technologies | Bonshell ASB C18 | Reversed-Phase | Silica/C18 | 2.1 mm | 30 mm | 2.7 μm | 90 Å | On request |
| Teknokroma | Europa Protein 300 C18 | Reversed-Phase | Silica/C18 | 10.0 mm | 100 mm | 5.0 μm | 300 Å | On request |
| CNW Technologies | Athena C18-WP | Reversed-Phase | Silica/C18 | 4.6 mm | 50 mm | 5.0 μm | 100 Å | On request |
No customer reviews yet. Be the first to share your experience!